Dr. Carol Salzman, MD,PHD Internal Medicine - Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 5530 Wisconsin Ave, Suite 800, Chevy Chase, MD 20815 Phone: 301-657-9424 Fax: 301-656-6971 |
Dr. Michail Lionakis, Internal Medicine - Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 4515 Willard Ave Apt 1415s, Chevy Chase, MD 20815 Phone: 832-661-5976 |
Dr. Deidra Evans Woods, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 5530 Wisconsin Ave, Ste 1400, Chevy Chase, MD 20815 Phone: 301-656-9170 Fax: 301-654-5893 |
Dr. Michael Johnson, MD Internal Medicine - Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 4424 Stanford St, Chevy Chase, MD 20815 Phone: 202-704-2914 |
News Archive
Democrats in Congress and the White House are feverishly negotiating to pass as much of President Joe Biden's domestic agenda as they can agree on, even as Republicans who oppose much of the increased spending threaten to shut down the government and default on the nation's debt.
Medical Web Technologies today announced that Wentworth-Douglass Hospital, the largest acute care hospital in the Seacoast, has successfully taken its pre-operative process online with One Medical Passport. Since implementing One Medical Passport, Wentworth-Douglass has lowered operating costs, increased patient satisfaction, and reclaimed valuable nurse time.
Archives of Internal Medicine: Physician Professionalism And Changes in Physician-Industry Relationships From 2004 to 2009 -"During the last 6 years a number of efforts have aimed to reduce, and in some cases eliminate, certain types of physician-industry relationships (PIRs)," including policies "that forbid physicians from accepting samples and receiving food and beverages in offices, limiting company representatives' access to physicians' offices and clinical areas, and banning faculty participation in speaker bureaus and other forms of promotional activity," write the authors.
Executives from Heptares Therapeutics (Welwyn Garden City, UK) and O2h (Cambridge, UK) announced today an extension of the agreement under which O2h provides multi-FTE -synthetic chemistry services to support discovery programmes at Heptares.
› Verified 2 days ago